New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics. Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens footprint of Merck in fast-growing Asia-Pacific region Investment to create up to 300 additional jobs DARMSTADT, GERMANY […]

Following successful, fully subscribed Early Access and Beta Programs, Elegen’s latest ENFINIA™ DNA enhancement provides access to very challenging sequences, including long repeats and STRs, GC-rich promoters, enhancers, terminators, ITRs, LTRs and homopolymers. Elegen is the only DNA manufacturer delivering the unique combination of industry-leading complexity, length and NGS-verified accuracy within days, streamlining workflows and […]

Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapies by offering decentralized genomic testing and rapid turnaround time BERLIN & CARLSBAD, Calif. — Bayer AG and Thermo Fisher Scientific Inc. today announced to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help […]

HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader […]

Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Program Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening […]

New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU MOUNTAIN VIEW, Calif. — –DNAnexus, Inc., the provider of the Precision Health Data Cloud, today announced that it is integrating new NVIDIA NIM and CUDA-X microservices. These microservices are designed to allow […]

Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), continues to lead the way with first-to-market concepts with the launch of the CytoFLEX nano Flow Cytometer – the first purpose-built […]

Produced using a patented dry-spinning technology – CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering a highly accurate representation of in-vivo conditions. These innovative collagen fibres are seamlessly produced on a commercial scale using an automated state-of-the-art Good Manufacturing Process, […]

MENADNA Inc., has entered into an exclusive partnership with ProPhase Labs’ subsidiary, Nebula Genomics, aiming to advance genomic testing in Jordan, Oman, and Iraq. This collaboration will leverage Nebula Genomics’ advanced sequencing technologies and MENADNA’s bioinformatics capabilities to improve the quality and relevance of genomic data in these historically underserved regions. Pleasanton, CA — MENADNA […]

GLENDALE HEIGHTS, Ill. — Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos’ […]